Assay of Ascorbic Acid in a Radiopharmaceutical Preparation for the Treatment of Bone Metastases

Author： Épshtein N.   Artamonova L.   Skvortsov V.   Khomushku G.   Shilina A.   Kharitonov Yu.  

Publisher： Springer Publishing Company

ISSN： 0091-150X

Source： Pharmaceutical Chemistry Journal, Vol.47, Iss.8, 2013-11, pp. : 446-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ibandronic Acid: A Review of its Use in the Treatment of Bone Metastases of Breast Cancer

By McCormack Paul L.   Plosker Greg L.  

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 711-728

Adis International

Access to resources Recommend Favorite

Bisphosphonates as Treatment of Bone Metastases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1262-1271

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention and Treatment of Bone Metastases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 27, 2010-09 ,pp. : 2998-3006

Bentham Science Publishers

Access to resources Recommend Favorite

Clodronic acid reduces bone metastases

By  

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Bisphosphonate Treatment of Lytic Bone Metastases

By Lipton A.  

Drugs & Aging, Vol. 14, Iss. 4, 1999-04 ,pp. : 241-246

Adis International

Access to resources Recommend Favorite